Latest Insider Transactions at Fibrogen Inc (FGEN)
This section provides a real-time view of insider transactions for Fibrogen Inc (FGEN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of FIBROGEN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of FIBROGEN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 07
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-0.64%
|
$0
$0.34 P/Share
|
|
Dec 06
2024
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,792
-0.92%
|
$0
$0.34 P/Share
|
|
Dec 06
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,363
-0.56%
|
$0
$0.34 P/Share
|
|
Dec 06
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,446
-0.86%
|
$0
$0.34 P/Share
|
|
Sep 07
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,065
-0.63%
|
$0
$0.39 P/Share
|
|
Sep 06
2024
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
17,395
-5.41%
|
$0
$0.39 P/Share
|
|
Sep 06
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,363
-0.56%
|
$0
$0.39 P/Share
|
|
Sep 06
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
16,050
-8.7%
|
$0
$0.39 P/Share
|
|
Aug 01
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,840
-4.68%
|
$0
$0.47 P/Share
|
|
Jun 22
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-0.18%
|
$782
$1.13 P/Share
|
|
Jun 12
2024
|
Deyaa Adib Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
22,123
+21.22%
|
$22,123
$1.17 P/Share
|
|
Jun 07
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,182
-0.64%
|
$1,182
$1.1 P/Share
|
|
Jun 06
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17,797
-8.75%
|
$17,797
$1.19 P/Share
|
|
Jun 06
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,255
-0.5%
|
$2,255
$1.19 P/Share
|
|
Jun 06
2024
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
19,289
-5.66%
|
$19,289
$1.19 P/Share
|
|
May 01
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,840
-4.44%
|
$20,840
$1.17 P/Share
|
|
Mar 22
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
782
-0.17%
|
$1,564
$2.58 P/Share
|
|
Mar 07
2024
|
Thane Wettig CEO |
BUY
Open market or private purchase
|
Direct |
50,000
+9.61%
|
$50,000
$1.91 P/Share
|
|
Mar 07
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,181
-0.58%
|
$1,181
$1.79 P/Share
|
|
Mar 06
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
20,749
-4.63%
|
$20,749
$1.87 P/Share
|
|
Mar 06
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
781
+0.38%
|
-
|
|
Mar 06
2024
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
23,590
-3.25%
|
$23,590
$1.87 P/Share
|
|
Mar 06
2024
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
781
+0.23%
|
-
|
|
Mar 06
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,535
-0.54%
|
$4,535
$1.87 P/Share
|
|
Mar 06
2024
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
781
+0.19%
|
-
|
|
Feb 21
2024
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+7.38%
|
-
|
|
Feb 21
2024
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
166,000
+28.14%
|
-
|
|
Feb 21
2024
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,000
+18.8%
|
-
|
|
Feb 01
2024
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,490
-8.35%
|
$46,980
$2.37 P/Share
|
|
Dec 22
2023
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-0.29%
|
$0
$0.76 P/Share
|
|
Dec 07
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-0.62%
|
$0
$0.62 P/Share
|
|
Dec 06
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
18,182
-5.15%
|
$0
$0.58 P/Share
|
|
Dec 06
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,573
-8.23%
|
$0
$0.58 P/Share
|
|
Dec 06
2023
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,680
-0.59%
|
$0
$0.58 P/Share
|
|
Nov 01
2023
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,841
-7.14%
|
$0
$0.55 P/Share
|
|
Sep 22
2023
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-0.27%
|
$0
$0.79 P/Share
|
|
Sep 07
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,096
-0.58%
|
$0
$0.99 P/Share
|
|
Sep 06
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,860
-1.15%
|
$0
$0.96 P/Share
|
|
Sep 06
2023
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,680
-0.55%
|
$0
$0.96 P/Share
|
|
Sep 06
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-0.37%
|
$0
$0.96 P/Share
|
|
Sep 06
2023
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,308
-0.93%
|
$0
$0.96 P/Share
|
|
Sep 01
2023
|
Jeffrey William Henderson Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.48%
|
$2,000
$1.03 P/Share
|
|
Sep 01
2023
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,085
-0.67%
|
$1,085
$1.06 P/Share
|
|
Aug 30
2023
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+25.19%
|
-
|
|
Aug 30
2023
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+38.57%
|
-
|
|
Aug 07
2023
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+39.35%
|
-
|
|
Aug 04
2023
|
Jeffrey William Henderson Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.09%
|
$2,000
$1.91 P/Share
|
|
Jul 11
2023
|
Jeffrey William Henderson Director |
SELL
Open market or private sale
|
Direct |
2,000
-5.74%
|
$4,000
$2.69 P/Share
|
|
Jul 07
2023
|
Enrique A Conterno Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,880
-0.5%
|
$3,760
$2.8 P/Share
|
|
Jun 23
2023
|
Thane Wettig CEO |
SELL
Open market or private sale
|
Direct |
791
-0.73%
|
$12,656
$16.53 P/Share
|